Leading Pre-Launch Excellence in Specialized Medicines for Rare Disease

Rare Affairs Consulting specialise in supporting rare disease medicines in the pre-launch and launch space, with expert skills in:

Medical strategy and launch planning
Advisory boards, consultancies and insight generation
KOL identification and engagement
Peer-to-peer medical education
Data releases and congress support
Medical science liaison activities including materials

We are available to help on short term project deliverables or longer term product support.

Schedule a Free Consultation

Services

Expert medical affairs support in the pre-launch setting from short individual projects to long term on-going product support in the UK marketplace.

Medical strategy and launch planning

We craft evidence-based strategies to position rare disease therapies for UK market success, ensuring regulatory alignment, national and sub-national access and stakeholder readiness.

Advisory boards, consultancies and insight generation

We expertly facilitate advisory boards and 1:1 consultancies with TAEs, HCPs and other relevant decision makers, to deliver actionable insights that refine launch strategies or assist in key decision making processes.

KOL identification and engagement

We can identify and engage key opinion leaders for therapy area, partnering to build trust and cultivate personal engagements that deliver on your strategic objectives.

Peer-to-peer medical education

Unbranded and product-specific medical education plays a key role in improving HCP understanding and, in turn, patient outcomes. We partner with established HCPs in your therapy area to develop and deliver relevant education in a format your customers want.

Data releases and congress support

We can develop and organise your presence at local and international congress. From ENCORES to national symposia, we partner with key TAEs to ensure an engaging congress experiences aligned with your customer needs.

Medical science liaison activities including materials

We develop engaging science-driven non-promotional materials for pre-launch engagement requests. Pre-launch medical engagement plans focused on insight generation and desk top research. We can act as an interim MSL when needed.